Large gap with delayed quotes
|
Last quote
01/17/2026
-
02:00:00
|
Bid
01/16/2026 -
21:59:59
|
Bid Volume |
Ask
01/16/2026 -
21:59:59
|
Ask Volume |
|---|---|---|---|---|
|
68.67
-1.29
(
-1.84% )
|
68.68
|
200 |
68.70
|
7,400 |
Analysis date: 16.01.2026
Global Evaluation
Slightly negative
Slightly negative
The stock is classified in the slightly negative zone since 02.12.2025.
Interest
Weak
Weak
Two stars since 06.01.2026.
Earnings Rev Trend
-0.10
-0.10
Compared to seven weeks ago, the analysts have not significantly revised their earnings per share estimates (changes between +1% and -1% are considered neutral). But the last significant trend is negative since 26.12.2025 at a price of 59.22.
Evaluation
Overvalued
Overvalued
Based on its growth potential and our own criteria, we believe the share price is currently moderately overvalued.
MT Tech Trend
Positive
Positive
The dividend-adjusted forty day technical trend is positive since 06.01.2026.
4wk Rel Perf
17.50%
17.50%
The four-week dividend-adjusted overperformance versus SP500 is 17.50%.
Sensibility
High
High
The stock has been on the high-sensitivity level since 02.12.2025.
Bear Market Factor
Middle
Middle
On average, the stock is likely to decline with the index.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 3.45%.
Mkt Cap in $bn
10.90
10.90
With a market capitalization >$8bn, BIO-TECHNE is considered a large-cap stock.
G/PE Ratio
0.72
0.72
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) below 0.9 indicates that investors must pay a premium for the estimated growth potential:
LT P/E
27.39
27.39
The estimated PE is for the year 2028.
LT Growth
19.25%
19.25%
The annualized growth estimate is for the current year to 2028.
Avg. Nb analysts
12
12
Over the last seven weeks, an average of 12 analysts provided earnings per share estimates.
Dividend Yield
0.47%
0.47%
The twelve month estimated dividend yield represents 12.76% of earnings forecasts.
Beta
105
105
For 1% of index variation, the stock varies on average by 1.05%.
Correlation
0.47
0.47
47.33% of stock movements are explained by index variations.
Value at Risk
31.44
31.44
The value at risk is estimated at USD 31.44. The risk is therefore 45.79%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
31.03.2004
31.03.2004